not tagged
bms
['nsclc', 'thoracic', 'sclc', 'scienceatbms', 'bms']
we are excited to be part of #esmo22! join us in poster area, hall 4 for new 3-year survival data of first-line dual #immunotherapy + 2 cycles of chemo in patients with metastatic #nsclc having high unmet needs; #thoraciccancers 
Official Bristol Myers Squibb Twitter handle for science. Connecting researchers, scientists and healthcare professionals through science; guidelines below: